<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Clinical Trials & Tribulations

Pancreatic cancer survival edges up—as screening strategies emerge

January 20, 2023

BYLINE DOWNLOAD PDF TABLE OF CONTENTS

The American Cancer Society’s Cancer Facts & Figures 2023, released last week, reports that the five-year survival rate for pancreatic cancer is now 12%, an increase of one percentage point from last year.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe

Byline

Rosario Ligresti, MD

<img width="300" height="300" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%20300%20300'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2023/01/20011956/Rosario-Ligrest_squarei-300x300.jpg" class="w_100p bgc_w lazy" alt="Rosario Ligresti, MD" loading="lazy" data-srcset="https://cdn.cancerletter.com/media/2023/01/20011956/Rosario-Ligrest_squarei-300x300.jpg 300w, https://cdn.cancerletter.com/media/2023/01/20011956/Rosario-Ligrest_squarei-250x250.jpg 250w, https://cdn.cancerletter.com/media/2023/01/20011956/Rosario-Ligrest_squarei.jpg 400w" data-sizes="(max-width: 300px) 100vw, 300px" />

Rosario Ligresti, MD

Chief, Division of Gastroenterology, John Theurer Cancer Center, Hackensack University Medical Center

DOWNLOAD THE PDF

Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

PRECEDE study points to screening method for pancreatic cancer

Research published in April in the Journal of the National Comprehensive Cancer Network showcases the feasibility of improving early detection and prevention for pancreatic cancer.

Clinical Roundup

Urine test improves non-invasive detection of prostate cancer

A urine test that measures 18 genes associated with prostate cancer provides higher accuracy for detecting clinically significant cancers than PSA and other existing biomarker tests, according to a study published April 18 in JAMA Oncology.

Clinical Trials & Tribulations

A new standard in cancer care: Integrated screening, stepped collaborative care for common and distressing symptoms

Over 18 million people are diagnosed with cancer in the United States and approximately 50% report clinical levels of depression and/or anxiety, pain, and/or fatigue. xxx:more

By Jennifer A. Steel

Anna Berkenblit named chief scientific and medical officer of PanCAN

Anna Berkenblit, a clinical oncologist and drug developer, was named the first-ever chief scientific and medical officer of the Pancreatic Cancer Action Network.

UVA, Southwest Virginia providers partner to boost CRC screening

The Community Health Center of the New River Valley and the University of Virginia Cancer Center partnered to boost southwest Virginia’s colorectal cancer screening rate by mailing at-home test kits to patients.

Diane Simeone begins work as director of Moores Cancer Center on April 1

Diane M. Simeone will become director of Moores Cancer Center at UC San Diego Health effective April 1.